Gut–Brain Axis: Influence of Gut Microbiota on Stress, Anxiety and Cognitive Functions.

The human gastrointestinal tract hosts trillions of microorganisms collectively known as the gut microbiota. These microorganisms include bacteria, viruses, fungi, and archaea that coexist symbiotically with the host and play essential roles in digestion, metabolism, immune regulation, and neurological health. Emerging evidence suggests that gut microbiota significantly influence brain development and function through a complex communication network called the gut–brain axis (1).

The gut–brain axis comprises bidirectional signaling pathways involving the enteric nervous system, vagus nerve, immune system, endocrine system, and microbial metabolites. Through these pathways, gut microorganisms can influence mood, behavior, cognition, and stress responses (2). The concept that intestinal microbes affect mental health has gained considerable attention over the last decade, leading to the development of the field of psychobiotics, which focuses on microbiome-based interventions for psychiatric disorders (3).

One of the primary mechanisms through which gut microbiota influence the brain is the modulation of neurotransmitter production. Several bacterial species produce neuroactive compounds, including gamma-aminobutyric acid (GABA), serotonin, dopamine, and acetylcholine. Approximately 90% of the body's serotonin is synthesized within the gastrointestinal tract, and microbial composition influences its production and availability (4). These neurotransmitters play crucial roles in emotional regulation, memory, learning, and stress adaptation.

Stress activates the hypothalamic–pituitary–adrenal (HPA) axis, resulting in the release of cortisol and other stress hormones. Chronic stress alters gut microbial diversity and intestinal permeability, leading to inflammation and dysbiosis. Conversely, gut microbiota can regulate HPA-axis activity and influence the body's stress response (5). Animal studies have demonstrated that germ-free mice exhibit exaggerated stress responses compared with conventionally colonized animals, suggesting a direct role of microbiota in stress regulation (6).

Anxiety disorders are among the most prevalent mental health conditions worldwide. Several studies have reported associations between altered gut microbial composition and anxiety-like behavior. Reduced abundance of beneficial bacterial genera such as Lactobacillus and Bifidobacterium has been observed in individuals experiencing chronic anxiety and psychological distress (7). Probiotic supplementation has shown promising effects in reducing anxiety symptoms and improving emotional well-being (8).

Cognitive functions such as learning, memory, attention, and executive processing are also influenced by the gut microbiome. Microbial metabolites, particularly short-chain fatty acids (SCFAs), contribute to neuroprotection, synaptic plasticity, and neurogenesis. Dysbiosis has been linked to impaired cognitive performance and increased risk of neurodegenerative disorders (9). Furthermore, chronic inflammation resulting from microbial imbalance can negatively affect neuronal function and cognitive outcomes (10).

Given the increasing prevalence of stress-related disorders and cognitive dysfunction, understanding the role of gut microbiota in brain health has become a major focus of biomedical research. Therefore, the present study aims to evaluate the influence of gut microbiota on stress, anxiety, and cognitive functions and to explore potential therapeutic implications of microbiome-targeted interventions.

This study was conducted as a narrative literature review and observational analysis examining the relationship between gut microbiota composition, stress, anxiety, and cognitive functions. Relevant scientific literature published between 2010 and 2024 was systematically reviewed.

Data Sources

Electronic databases including PubMed, Scopus, Web of Science, and Google Scholar were searched using the keywords:

•              Gut–brain axis

•              Gut microbiota

•              Stress response

•              Anxiety disorders

•              Cognitive function

•              Psychobiotics

•              Probiotics and mental health

•              Microbiome and cognition

Inclusion Criteria

Studies were included if they:

1.             Investigated the gut–brain axis in humans or animals.

2.             Evaluated stress, anxiety, or cognitive outcomes.

3.             Examined microbiota composition or microbiome interventions.

4.             Were published in peer-reviewed journals.

5.             Were written in English.

Exclusion Criteria

Studies were excluded if they:

1.             Were conference abstracts without full text.

2.             Did not examine neurological or psychological outcomes.

3.             Included insufficient methodological information.

4.             Were duplicate publications.

Data Extraction

Information extracted from eligible studies included:

•              Author and year

•              Study design

•              Sample size

•              Microbial characteristics

•              Stress and anxiety outcomes

•              Cognitive performance indicators

•              Main findings

Variables Evaluated

Independent Variables

•              Gut microbial diversity

•              Presence of beneficial bacteria

•              Probiotic supplementation

•              Dietary influences

Dependent Variables

•              Cortisol levels

•              Anxiety scores

•              Stress indices

•              Memory performance

•              Learning outcomes

Statistical Analysis

Data extracted from selected studies were organized and summarized using descriptive statistics. Mean values, percentages, and comparative analyses were used to evaluate trends. Results were presented using tables demonstrating relationships between microbiota composition and psychological outcomes.

Ethical Considerations

Since the study utilized previously published data and literature, ethical approval was not required. All reviewed articles were cited appropriately to maintain academic integrity and avoid plagiarism.

Table 1. Association Between Gut Microbiota and Stress Levels

Participants with severe dysbiosis demonstrated significantly elevated cortisol levels compared with individuals possessing healthy microbial diversity. These findings suggest that gut microbial imbalance may contribute to heightened physiological stress responses.

Table 2. Relationship Between Gut Microbiota and Anxiety Scores

Anxiety scores were considerably higher among individuals with dysbiosis. Probiotic intervention was associated with reduced anxiety symptoms, indicating potential therapeutic benefits of microbiome modulation.

Table 3. Cognitive Function Scores Across Groups

Healthy microbial composition was associated with superior cognitive performance. Probiotic supplementation improved memory, attention, and executive function compared with dysbiotic individuals.

The findings of this study support growing evidence that gut microbiota exert substantial influence on stress regulation, anxiety behavior, and cognitive performance. The gut–brain axis functions through multiple interconnected pathways involving neural signaling, endocrine responses, immune modulation, and microbial metabolites (2).

One of the major observations was the association between microbial imbalance and elevated cortisol levels. Cortisol is the principal stress hormone released following activation of the HPA axis. Previous studies have shown that germ-free animals display exaggerated HPA-axis responses when exposed to stressors, emphasizing the role of microbiota in neuroendocrine regulation (6). Healthy gut microbiota may therefore act as a protective factor against chronic stress.

The relationship between gut microbiota and anxiety is increasingly supported by clinical and experimental evidence. Beneficial bacteria such as Lactobacillus and Bifidobacterium produce metabolites that influence neurotransmitter pathways and reduce inflammatory signaling (7). Several randomized controlled trials have reported reductions in anxiety symptoms following probiotic supplementation, supporting the concept of psychobiotics as potential therapeutic agents (8). The lower anxiety scores observed in probiotic-treated groups within this study align with these findings.

The influence of gut microbiota on cognition represents another important area of investigation. Short-chain fatty acids, including butyrate, acetate, and propionate, produced through bacterial fermentation of dietary fibers, play critical roles in maintaining blood–brain barrier integrity and promoting neuroplasticity (9). These metabolites enhance synaptic function and support memory formation. Consequently, individuals with healthy microbial diversity often demonstrate superior cognitive performance.

Inflammation appears to be a central mechanism linking dysbiosis to cognitive dysfunction. Gut microbial imbalance can increase intestinal permeability, allowing bacterial endotoxins to enter systemic circulation and stimulate inflammatory pathways (10). Chronic neuroinflammation may impair hippocampal function, negatively affecting learning and memory processes. This mechanism may partly explain the reduced cognitive scores observed among dysbiotic individuals.

Dietary habits significantly influence microbiome composition and, consequently, mental health outcomes. Diets rich in fiber, fermented foods, fruits, and vegetables promote microbial diversity and beneficial metabolite production. Conversely, highly processed diets may contribute to dysbiosis and increased psychological distress (11). Therefore, nutritional interventions represent a practical strategy for improving gut and brain health simultaneously.

Recent advances in microbiome research have also highlighted the potential role of fecal microbiota transplantation, targeted probiotics, and personalized nutrition in treating neuropsychiatric conditions (12). While current evidence is promising, further large-scale clinical trials are needed to establish causality and determine optimal therapeutic approaches.

Overall, the present findings reinforce the concept that the gut microbiome is a key regulator of mental and cognitive health. Interventions aimed at restoring microbial balance may provide innovative strategies for preventing and managing stress-related disorders, anxiety, and cognitive decline.

The gut–brain axis represents a critical communication system linking intestinal microorganisms with neurological and psychological processes. Evidence reviewed in this study demonstrates that healthy gut microbiota contribute to reduced stress responses, lower anxiety levels, and improved cognitive performance. Dysbiosis is associated with elevated cortisol levels, increased anxiety symptoms, neuroinflammation, and cognitive impairment. Probiotic supplementation and dietary modifications appear beneficial in restoring microbial balance and supporting mental health. Future research should focus on personalized microbiome-based therapies to improve psychological well-being and cognitive function.

1.       Cryan JF, O'Riordan KJ, Cowan CSM, Sandhu KV, Bastiaanssen TFS, Boehme M, et al. The microbiota-gut-brain axis. Physiol Rev. 2019;99(4):1877–2013.

2.       Carabotti M, Scirocco A, Maselli MA, Severi C. The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems. Ann Gastroenterol. 2015;28(2):203–9.

3.       Dinan TG, Stanton C, Cryan JF. Psychobiotics: a novel class of psychotropic. Biol Psychiatry. 2013;74(10):720–6.

4.       Yano JM, Yu K, Donaldson GP, Shastri GG, Ann P, Ma L, et al. Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell. 2015;161(2):264–76.

5.       Foster JA, McVey Neufeld KA. Gut-brain axis: how the microbiome influences anxiety and depression. Trends Neurosci. 2013;36(5):305–12.

6.       Sudo N, Chida Y, Aiba Y, Sonoda J, Oyama N, Yu XN, et al. Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system. J Physiol. 2004;558(1):263–75.

7.       Jiang H, Ling Z, Zhang Y, Mao H, Ma Z, Yin Y, et al. Altered fecal microbiota composition in patients with generalized anxiety disorder. Brain Behav Immun. 2018;69:395–403.

8.       Wallace CJK, Milev R. The effects of probiotics on depressive symptoms in humans: a systematic review. Ann Gen Psychiatry. 2017;16:14.

9.       Dalile B, Van Oudenhove L, Vervliet B, Verbeke K. The role of short-chain fatty acids in microbiota-gut-brain communication. Nat Rev Gastroenterol Hepatol. 2019;16(8):461–78.

10.    Kelly JR, Borre Y, O'Brien C, Patterson E, El Aidy S, Deane J, et al. Transferring the blues: depression-associated gut microbiota induces neurobehavioral changes. J Psychiatr Res. 2016;82:109–18.

11.    Jacka FN, O'Neil A, Opie R, Itsiopoulos C, Cotton S, Mohebbi M, et al. A randomized controlled trial of dietary improvement for adults with major depression. BMC Med. 2017;15:23.

12.    Sarkar A, Lehto SM, Harty S, Dinan TG, Cryan JF, Burnet PW. Psychobiotics and the manipulation of bacteria-gut-brain signals. Trends Neurosci. 2016;39(11):763–81.